Psychosis in a case of schizophrenia and Parkinson's disease

Journal of Neuropsychiatry and Clinical Neurosciences

Volumn 20, Issue 3, 2008, Pages 373-375

  Habermeyer, Benedikt ^a   Kneifel, Stefan ^a   Lotz Bläuer, Irene ^a   Müller Spahn, Franz ^a  

^a UNIVERSITY OF BASEL   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

AMANTADINE; CLOZAPINE; ENTACAPONE; LEVODOPA; OLANZAPINE; PRAMIPEXOLE; QUETIAPINE;

AGED; CASE REPORT; COMORBIDITY; DELUSION; DRUG WITHDRAWAL; DYSKINESIA; HUMAN; LETTER; MALE; NEUROIMAGING; ON OFF PHENOMENON; PARANOID SCHIZOPHRENIA; PARKINSON DISEASE; PRIORITY JOURNAL; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY;

EID: 52649133985     PISSN: 08950172     EISSN: None     Source Type: Journal    
DOI: 10.1176/jnp.2008.20.3.373     Document Type: Letter

References (5)

1. Schwarz J, Scherer J, Trenkwalder C, et al: Reduced striatal dopaminergic innervation shown by IPT and SPECT in patients under neuroleptic treatment: need for levodopa therapy? Psychiatry Res 1998; 83:23-28
2. Winter C, Juckel G, Plotkin M, et al: Paranoid schizophrenia and idiopathic Parkinson's disease do coexist: a challenge for clinicians. Psychiatry Clin Neurosci 2006; 60:639
3. Plotkin M, Amthauer H, Klaffke S, et al: Combined 123I-FP-CIT and 123I-IBZM SPECT for the diagnosis of parkinsonian syndromes: study on 72 patients. J Neural Transm 2005; 112:677-692
4. Poewe W: Psychosis in Parkinson's disease. Mov Disord 2003; 18:S80-7
5. Merims D, Shabtai H, Korczyn AD, et al: Antiparkinsonian medication is not a risk factor for the development of hallucinations in Parkinson's disease. J Neural Transm 2004; 111:1447-1453